Clearstead Trust, LLC Catalent, Inc. Transaction History
Clearstead Trust, LLC
- $340 Million
- Q1 2024
A detailed history of Clearstead Trust, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Clearstead Trust, LLC holds 175 shares of CTLT stock, worth $9,889. This represents 0.0% of its overall portfolio holdings.
Number of Shares
175
Previous 175
-0.0%
Holding current value
$9,889
Previous $7,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CTLT
# of Institutions
484Shares Held
172MCall Options Held
865KPut Options Held
687K-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.2MShares$859 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA12.9MShares$730 Million0.12% of portfolio
-
Nomura Holdings Inc Tokyo, M011.3MShares$636 Million1.65% of portfolio
-
Janus Henderson Group PLC London, X09.56MShares$540 Million0.3% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.2B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...